These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


189 related items for PubMed ID: 7737279

  • 1. Antigen presentation by Leishmania mexicana-infected macrophages: activation of helper T cells specific for amastigote cysteine proteinases requires intracellular killing of the parasites.
    Wolfram M, Ilg T, Mottram JC, Overath P.
    Eur J Immunol; 1995 Apr; 25(4):1094-100. PubMed ID: 7737279
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Presentation of the protective parasite antigen LACK by Leishmania-infected macrophages.
    Prina E, Lang T, Glaichenhaus N, Antoine JC.
    J Immunol; 1996 Jun 01; 156(11):4318-27. PubMed ID: 8666803
    [Abstract] [Full Text] [Related]

  • 5. Leishmania-infected macrophages sequester endogenously synthesized parasite antigens from presentation to CD4+ T cells.
    Kima PE, Soong L, Chicharro C, Ruddle NH, McMahon-Pratt D.
    Eur J Immunol; 1996 Dec 01; 26(12):3163-9. PubMed ID: 8977318
    [Abstract] [Full Text] [Related]

  • 6. Antigen presentation capacity of murine macrophages infected with Leishmania amazonensis amastigotes.
    Prina E, Jouanne C, de Souza Lão S, Szabo A, Guillet JG, Antoine JC.
    J Immunol; 1993 Aug 15; 151(4):2050-61. PubMed ID: 8102156
    [Abstract] [Full Text] [Related]

  • 7. Acute cysticercosis favours rapid and more severe lesions caused by Leishmania major and Leishmania mexicana infection, a role for alternatively activated macrophages.
    Rodríguez-Sosa M, Rivera-Montoya I, Espinoza A, Romero-Grijalva M, López-Flores R, González J, Terrazas LI.
    Cell Immunol; 2006 Aug 15; 242(2):61-71. PubMed ID: 17118349
    [Abstract] [Full Text] [Related]

  • 8. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major.
    Doherty TM, Coffman RL.
    J Immunol; 1993 Jun 15; 150(12):5476-83. PubMed ID: 8515072
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Control of Leishmania major by a monoclonal alpha beta T cell repertoire.
    Reiner SL, Fowell DJ, Moskowitz NH, Swier K, Brown DR, Brown CR, Turck CW, Scott PA, Killeen N, Locksley RM.
    J Immunol; 1998 Jan 15; 160(2):884-9. PubMed ID: 9551925
    [Abstract] [Full Text] [Related]

  • 11. Presentation via the class I pathway by Leishmania amazonensis-infected macrophages of an endogenous leishmanial antigen to CD8+ T cells.
    Kima PE, Ruddle NH, McMahon-Pratt D.
    J Immunol; 1997 Aug 15; 159(4):1828-34. PubMed ID: 9257846
    [Abstract] [Full Text] [Related]

  • 12. T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.
    Torrentera FA, Glaichenhaus N, Laman JD, Carlier Y.
    Infect Immun; 2001 Jan 15; 69(1):617-21. PubMed ID: 11119565
    [Abstract] [Full Text] [Related]

  • 13. T-cell responsiveness of American cutaneous leishmaniasis patients to purified Leishmania pifanoi amastigote antigens and Leishmania braziliensis promastigote antigens: immunologic patterns associated with cure.
    Coutinho SG, Oliveira MP, Da-Cruz AM, De Luca PM, Mendonça SC, Bertho AL, Soong L, McMahon-Pratt D.
    Exp Parasitol; 1996 Nov 15; 84(2):144-55. PubMed ID: 8932764
    [Abstract] [Full Text] [Related]

  • 14. Murine cutaneous leishmaniasis: resistance correlates with the capacity to generate interferon-gamma in response to Leishmania antigens in vitro.
    Sadick MD, Locksley RM, Tubbs C, Raff HV.
    J Immunol; 1986 Jan 15; 136(2):655-61. PubMed ID: 3079789
    [Abstract] [Full Text] [Related]

  • 15. Trypanosoma cruzi-infected macrophages are defective in major histocompatibility complex class II antigen presentation.
    La Flamme AC, Kahn SJ, Rudensky AY, Van Voorhis WC.
    Eur J Immunol; 1997 Dec 15; 27(12):3085-94. PubMed ID: 9464791
    [Abstract] [Full Text] [Related]

  • 16. Genetic background influences immune responses and disease outcome of cutaneous L. mexicana infection in mice.
    Rosas LE, Keiser T, Barbi J, Satoskar AA, Septer A, Kaczmarek J, Lezama-Davila CM, Satoskar AR.
    Int Immunol; 2005 Oct 15; 17(10):1347-57. PubMed ID: 16141242
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
    Moll H, Flohé S, Röllinghoff M.
    Eur J Immunol; 1995 Mar 15; 25(3):693-9. PubMed ID: 7705398
    [Abstract] [Full Text] [Related]

  • 18. Uncompromised generation of a specific H-2DM-dependent peptide-MHC class II complex from exogenous antigen in Leishmania mexicana-infected dendritic cells.
    Bennett CL, Colledge L, Richards HE, Reay PA, Blackburn CC, Aebischer T.
    Eur J Immunol; 2003 Dec 15; 33(12):3504-13. PubMed ID: 14635061
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-T cell interaction in experimental visceral leishmaniasis: failure to express costimulatory molecules on Leishmania-infected macrophages and its implication in the suppression of cell-mediated immunity.
    Saha B, Das G, Vohra H, Ganguly NK, Mishra GC.
    Eur J Immunol; 1995 Sep 15; 25(9):2492-8. PubMed ID: 7589116
    [Abstract] [Full Text] [Related]

  • 20. Leishmania infantum-specific T cell lines derived from asymptomatic dogs that lyse infected macrophages in a major histocompatibility complex-restricted manner.
    Pinelli E, Gonzalo RM, Boog CJ, Rutten VP, Gebhard D, del Real G, Ruitenberg EJ.
    Eur J Immunol; 1995 Jun 15; 25(6):1594-600. PubMed ID: 7614987
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.